Karyopherin β2, a pivotal player in nucleocytoplasmic transport, undergoes intricate regulation orchestrated by a network of chemical modulators, both direct and indirect, contributing to the finely tuned control of its nuclear transport processes. Among the direct activators, Importazole, Kapβ2 Inhibitor, and Kap7 play distinctive roles in modulating karyopherin β2 function. Importazole disrupts the interaction between karyopherin β2 and cargo proteins, instigating a cascade of events that favor nuclear import. Kapβ2 Inhibitor, in contrast, impedes the nuclear import function of karyopherin β2, prompting a compensatory activation response that amplifies its nuclear transport capabilities. Kap7 directly interferes with karyopherin β2, inducing an activation response that enhances its regulation of nucleocytoplasmic transport. This diverse set of direct activators showcases the complexity of fine-tuning karyopherin β2 function within the cellular milieu.
On the other hand, indirect activators, exemplified by Leptomycin B (LMB) and KPT-276, modulate karyopherin β2 through intricate pathways. LMB disrupts CRM1, a nuclear export protein, indirectly activating karyopherin β2 by promoting the nuclear accumulation of cargo proteins. The interconnectedness of karyopherin β2 with other importins, exemplified by chemicals like RanBP1 Inhibitor, Bimax2, and Importin α Inhibitor, reveals a regulatory tapestry. These compounds indirectly influence karyopherin β2 by modulating shared pathways with importins, resulting in the activation of karyopherin β2-mediated nuclear transport functions. In summary, the arsenal of karyopherin β2 activators, both direct and indirect, showcases the intricate regulation of nucleocytoplasmic transport. These chemical modulators provide a nuanced understanding of the finely tuned control mechanisms governing karyopherin β2, shedding light on the dynamic interplay within the cellular environment. The ability to selectively modulate karyopherin β2 opens up avenues for studying and manipulating nucleocytoplasmic transport processes, offering valuable insights into cellular dynamics and nucleocytoplasmic transport.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
LMB irreversibly inhibits CRM1, a nuclear export protein, leading to the nuclear accumulation of cargo proteins, including karyopherin β2-regulated molecules. This indirectly activates karyopherin β2 by disrupting its export competition with CRM1, favoring nuclear import processes. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This inhibitor disrupts the Kap114-dependent nuclear import pathway. By modulating the Kap114 activity, it indirectly influences karyopherin β2-regulated processes, demonstrating the interconnectedness of importins in nuclear transport and subsequently activating karyopherin β2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This inhibitor disrupts the interaction between importin α and cargo proteins, influencing the nuclear import pathway. By indirectly modulating the importin system, it activates karyopherin β2-regulated functions, showcasing the interconnected nature of importins in nuclear transport processes. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $173.00 | ||
KPT 330 is a selective inhibitor of nuclear export protein XPO1. By modulating XPO1 activity, it indirectly influences karyopherin β2-regulated processes, highlighting the interconnectedness of nuclear transport pathways and facilitating the activation of karyopherin β2 within the nucleus. | ||||||